Advanced search
1 file | 377.35 KB Add to list

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

(2018) LEUKEMIA. 32(1). p.244-248
Author
Organization
Keywords
NOVO PURINE SYNTHESIS, RANDOMIZED-TRIAL, TEL-AML1 FUSION, ONCOLOGY-GROUP, PHASE-3 TRIAL, THERAPY, DEXAMETHASONE, CHILDREN, PROTOCOL, CANCER

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 377.35 KB

Citation

Please use this url to cite or link to this publication:

MLA
Piette, C, S Suciu, E Clappier, et al. “Differential Impact of Drugs on the Outcome of ETV6-RUNX1 Positive Childhood B-cell Precursor Acute Lymphoblastic Leukaemia : Results of the EORTC CLG 58881 and 58951 Trials.” LEUKEMIA 32.1 (2018): 244–248. Print.
APA
Piette, C., Suciu, S., Clappier, E., Bertrand, Y., Drunat, S., Girard, S., Yakouben, K., et al. (2018). Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials. LEUKEMIA, 32(1), 244–248.
Chicago author-date
Piette, C, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, et al. 2018. “Differential Impact of Drugs on the Outcome of ETV6-RUNX1 Positive Childhood B-cell Precursor Acute Lymphoblastic Leukaemia : Results of the EORTC CLG 58881 and 58951 Trials.” Leukemia 32 (1): 244–248.
Chicago author-date (all authors)
Piette, C, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, N Grardel, Nadine Van Roy, A Uyttebroeck, V Costa, O Minckes, N Sirvent, P Simon, P Lutz, A Ferster, C Pluchart, M Poiree, C Freycon, M-F Dresse, F Millot, C Chantrain, J van der Werff ten Bosch, K Norga, C Gilotay, P-S Rohrlich, Yves Benoit, and H Cave. 2018. “Differential Impact of Drugs on the Outcome of ETV6-RUNX1 Positive Childhood B-cell Precursor Acute Lymphoblastic Leukaemia : Results of the EORTC CLG 58881 and 58951 Trials.” Leukemia 32 (1): 244–248.
Vancouver
1.
Piette C, Suciu S, Clappier E, Bertrand Y, Drunat S, Girard S, et al. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials. LEUKEMIA. 2018;32(1):244–8.
IEEE
[1]
C. Piette et al., “Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials,” LEUKEMIA, vol. 32, no. 1, pp. 244–248, 2018.
@article{8549771,
  author       = {Piette, C and Suciu, S and Clappier, E and Bertrand, Y and Drunat, S and Girard, S and Yakouben, K and Plat, G and Dastugue, N and Mazingue, F and Grardel, N and Van Roy, Nadine and Uyttebroeck, A and Costa, V and Minckes, O and Sirvent, N and Simon, P and Lutz, P and Ferster, A and Pluchart, C and Poiree, M and Freycon, C and Dresse, M-F and Millot, F and Chantrain, C and van der Werff ten Bosch, J and Norga, K and Gilotay, C and Rohrlich, P-S and Benoit, Yves and Cave, H},
  issn         = {0887-6924},
  journal      = {LEUKEMIA},
  keywords     = {NOVO PURINE SYNTHESIS,RANDOMIZED-TRIAL,TEL-AML1 FUSION,ONCOLOGY-GROUP,PHASE-3 TRIAL,THERAPY,DEXAMETHASONE,CHILDREN,PROTOCOL,CANCER},
  language     = {eng},
  number       = {1},
  pages        = {244--248},
  title        = {Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials},
  url          = {http://dx.doi.org/10.1038/leu.2017.289},
  volume       = {32},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: